Method Meta-analysis
Lead Research Organisation:
University College London
Department Name: UNLISTED
Abstract
Systematic reviews are a way of bringing together similar clinical trials. Meta-analysis is a way of putting results or data from these trials together to work out whether treatments work, and network meta-analysis helps us decide which treatments work best.
Working alongside trial teams, we are developing new and improved ways of planning and doing these systematic reviews and meta-analyses, so that we can find out which treatments are best for patients quickly and reliably. Sometimes, treatments work better in some patients than in others, so we are also collecting more detailed data and developing reliable methods to explore this. We are developing better statistical techniques for doing all types of meta-analysis and network meta-analysis. To help others to use our new methods of doing things, we are writing user-friendly software, preparing guidance, and giving tutorials and training courses.
Working alongside trial teams, we are developing new and improved ways of planning and doing these systematic reviews and meta-analyses, so that we can find out which treatments are best for patients quickly and reliably. Sometimes, treatments work better in some patients than in others, so we are also collecting more detailed data and developing reliable methods to explore this. We are developing better statistical techniques for doing all types of meta-analysis and network meta-analysis. To help others to use our new methods of doing things, we are writing user-friendly software, preparing guidance, and giving tutorials and training courses.
Technical Summary
Systematic review and meta-analysis are essential tools for rigorously evaluating the effects of therapies, particularly integrating our trial results with those of other groups, and informing the design of our trials. This programme develops the methodology underpinning systematic reviews and meta-analyses, applies it in high-quality reviews relevant to our trials, and disseminates it to the scientific community. Interaction between systematic reviewers, methodologists and trialists is fundamental to these endeavours.
We have particular experience and an international reputation in the conduct of large collaborative systematic reviews and meta-analyses based individual participant data (IPD). Over more than 20 years, these have influenced the treatment of patients globally, and moreover, the data have been used to investigate methodological issues and develop robust solutions. However, such IPD meta-analyses are time- and resource-intensive, so a key aim is to establish when they are most needed to answer clinical questions reliably. Conversely, if aggregate data approaches are to provide a robust and speedier alternative, we need to move beyond the current methods of doing these, in order to limit the inherent biases.
With some clinical areas moving rapidly, there can be multiple trials comparing different treatments to one or more standard. This means that there is sometimes little opportunity for direct comparisons, so we also need the most robust and timely methods for network meta-analysis. We refer to pairwise meta-analysis (directly comparing two treatments) as MA and network meta-analysis (directly and indirectly comparing many treatments) as NMA.
In this area, we benefit from the arrival of new senior staff in 2017, which has substantially broadened our expertise in statistical modelling for MA and NMA. Our future plans will continue to integrate this expertise into our ongoing programme of work. For example, we will develop and implement state-of-the-art methodology in MA and NMA of time-to-event outcomes based on individual participant data (IPD), informing overall and stratified treatment decisions, while allowing for complexities in the design of the component trials, heterogeneity between trials, and inconsistency between direct and indirect evidence.
Our overall philosophy is to use the simplest methods that can be shown to be valid (often by methodological comparison with more complex methods), and wherever possible to work prospectively and collaboratively to reduce bias, increase the timeliness of our reviews, and achieve greater impact.
Our research covers four priority areas:
1. Beyond standard systematic reviews – developing review methods that move beyond standard approaches and using them to perform high-quality and challenging reviews
2. Determining methods to assess which participants benefit most from treatments in pairwise and network meta-analysis
3. Choosing and building appropriate models for in pairwise and network meta-analysis
4. Guidance and tools to increase impact of our meta-analysis methods
We have particular experience and an international reputation in the conduct of large collaborative systematic reviews and meta-analyses based individual participant data (IPD). Over more than 20 years, these have influenced the treatment of patients globally, and moreover, the data have been used to investigate methodological issues and develop robust solutions. However, such IPD meta-analyses are time- and resource-intensive, so a key aim is to establish when they are most needed to answer clinical questions reliably. Conversely, if aggregate data approaches are to provide a robust and speedier alternative, we need to move beyond the current methods of doing these, in order to limit the inherent biases.
With some clinical areas moving rapidly, there can be multiple trials comparing different treatments to one or more standard. This means that there is sometimes little opportunity for direct comparisons, so we also need the most robust and timely methods for network meta-analysis. We refer to pairwise meta-analysis (directly comparing two treatments) as MA and network meta-analysis (directly and indirectly comparing many treatments) as NMA.
In this area, we benefit from the arrival of new senior staff in 2017, which has substantially broadened our expertise in statistical modelling for MA and NMA. Our future plans will continue to integrate this expertise into our ongoing programme of work. For example, we will develop and implement state-of-the-art methodology in MA and NMA of time-to-event outcomes based on individual participant data (IPD), informing overall and stratified treatment decisions, while allowing for complexities in the design of the component trials, heterogeneity between trials, and inconsistency between direct and indirect evidence.
Our overall philosophy is to use the simplest methods that can be shown to be valid (often by methodological comparison with more complex methods), and wherever possible to work prospectively and collaboratively to reduce bias, increase the timeliness of our reviews, and achieve greater impact.
Our research covers four priority areas:
1. Beyond standard systematic reviews – developing review methods that move beyond standard approaches and using them to perform high-quality and challenging reviews
2. Determining methods to assess which participants benefit most from treatments in pairwise and network meta-analysis
3. Choosing and building appropriate models for in pairwise and network meta-analysis
4. Guidance and tools to increase impact of our meta-analysis methods
Organisations
- University College London (Lead Research Organisation)
- Fiona Stanley Hospital (Collaboration)
- University of Granada (Collaboration)
- Carolina Urologic Research Center (Collaboration)
- Medical University of Vienna (Collaboration)
- Kindai University Hospital (Collaboration)
- Prostate Cancer Foundation (Collaboration)
- Pumping Marvellous Foundation (Collaboration)
- Hospital Reina Sofía de Córdoba (Collaboration)
- Massachusetts General Hospital (Collaboration)
- Saint Louis University (Collaboration)
- Epsom and St Helier University Hospitals NHS Trust (Collaboration)
- McMaster University (Collaboration)
- Somerset NHS Foundation Trust (Collaboration)
- The Methodist Hospital, Houston (Collaboration)
- Public Assistance - Hospitals of Paris (Collaboration)
- UNIVERSITY OF BIRMINGHAM (Collaboration)
- Yokohama City University Medical Centre (Collaboration)
- University of Paris (Collaboration)
- Radboud University Nijmegen (Collaboration)
- Salford Royal Hospital (Collaboration)
- Oslo University Hospital (Collaboration)
- UNIVERSITY OF SYDNEY (Collaboration)
- Sapienza University of Rome (Collaboration)
- University of Port Harcourt Teaching Hospital (Collaboration)
- Circolo Hospital and Macchi Foundation (Collaboration)
- Erasmus MC (Collaboration)
- University of Miami (Collaboration)
- Mohamed V University (Collaboration)
- Akershus University Hospital (Collaboration)
- UNIVERSITY OF OXFORD (Collaboration)
- Royal Victoria Hospital, Belfast (Collaboration)
- University of Maryland, College Park (Collaboration)
- Belfast City Hospital (Collaboration)
- Institute of Cancer Research UK (Collaboration)
- University of Lille (Collaboration)
- Yale University (Collaboration)
- University Hospital of Valme (Collaboration)
- Santa Chiara Hospital (Collaboration)
- Toho University Medical Center Sakura Hospital (Collaboration)
- University of Twente (Collaboration)
- Grochowski Hospital (Collaboration)
- Umea University (Collaboration)
- Tel Aviv University (Collaboration)
- Netherlands Cancer Institute (NKI) (Collaboration)
- University of Leipzig (Collaboration)
- Guy's and St Thomas' NHS Foundation Trust (Collaboration)
- Hospital de Sant Pau (Collaboration)
- University of Adelaide (Collaboration)
- UNIVERSITY OF LIVERPOOL (Collaboration)
- Beneficência Portuguesa de São Paulo (Collaboration)
- Acibadem University (Collaboration)
- National Institute for Health Research (Collaboration)
- Genentech, Inc (Collaboration)
- IMPERIAL COLLEGE LONDON (Collaboration)
- University of California, Davis (Collaboration)
- Skåne University Hospital (Collaboration)
- Duke University (Collaboration)
- Hospital Ramón y Cajal (Collaboration)
- University Hospital Erlangen (Collaboration)
- Institute of Health Carlos III (Collaboration)
- Sheffield Teaching Hospitals NHS Foundation Trust (Collaboration)
- Lille University Hospital (Collaboration)
- University Hospital La Princesa (Collaboration)
- Karolinska Institute (Collaboration)
- Connolly Hospital Blanchardstown (Collaboration)
- University of York (Collaboration)
- University of California, San Francisco (Collaboration)
- Leiden University Medical Center (Collaboration)
- Oregon Health and Science University (Collaboration)
- Sahlgrenska University Hospital (Collaboration)
- University of Pennsylvania (Collaboration)
- NRG Oncology (Collaboration)
- Fudan University (Collaboration)
- UNIVERSITY OF SOUTHAMPTON (Collaboration)
- University of Côte d'Azur (Collaboration)
- HARVARD UNIVERSITY (Collaboration)
- University of Wisconsin-Madison (Collaboration)
- San Raffaele Hospital (Collaboration)
- National Institute of Health and Medical Research (INSERM) (Collaboration)
- Li Ka Shing Foundation (Collaboration)
- George Institute for Global Health (Collaboration)
- University of Paris - Descartes (Collaboration)
- Berry Consultants LLC (Collaboration)
- University of Chicago Medical Center (Collaboration)
- Gustave-Roussy Institute (Collaboration)
- St Luke's Hospital, Dublin (Collaboration)
- NewYork–Presbyterian Hospital (Collaboration)
- University of Toronto (Collaboration)
- Saitama Medical University (Collaboration)
- UNIVERSITY OF BRITISH COLUMBIA (Collaboration)
- University of Glasgow (Collaboration)
- University of Paris-Saclay (Collaboration)
- Ministry of Health (Collaboration)
- University of Groningen (Collaboration)
- University of Bologna (Collaboration)
- Instituto de Investigación Biomédica de Málaga (Collaboration)
- Karolinska University Hospital (Collaboration)
- Hospital Universitario Puerta de Hierro (Collaboration)
- Sanofi (Collaboration)
- Hong Kong Sanatorium and Hospital (Collaboration)
- University of Queensland (Collaboration)
- University of Lugano (Collaboration)
- Albert Ludwig University of Freiburg (Collaboration)
- Paoli-Calmettes Institute (Collaboration)
- University of Milan (Collaboration)
- World Health Organization (WHO) (Collaboration)
- University College London (Collaboration)
- Mount Vernon Hospital (Collaboration)
- BARTS HEALTH NHS TRUST (Collaboration)
- Necker-Enfants Malades Hospital (Collaboration)
- University of Western Australia (Collaboration)
- Ankara University (Collaboration)
- Vall d'Hebron Institute of Oncology (Collaboration)
- University of North Carolina at Chapel Hill (Collaboration)
- American University of Beirut Medical Center (Collaboration)
- Maastricht University (UM) (Collaboration)
- Innlandet Hospital Trust (Collaboration)
- Queen's Medical Center (Collaboration)
- Hospital 12 de Octubre (Collaboration)
- Walsall College (Collaboration)
- The Hospital Israelita Albert Einstein (Collaboration)
- Saarland University (Collaboration)
- University of Washington (Collaboration)
- Tampere University Hospital (Collaboration)
- University of Zurich (Collaboration)
- KEELE UNIVERSITY (Collaboration)
- Sun Yat-sen University (Collaboration)
- Baylor College of Medicine (Collaboration)
- University of Minnesota (Collaboration)
- King Saud University (Collaboration)
- University Children's Hospital Zurich (Collaboration)
- Vanderbilt University (Collaboration)
- Hospitals Essen-Mitte (Collaboration)
- Johns Hopkins University (Collaboration)
- Stanford University (Collaboration)
- Icahn School of Medicine at Mount Sinai (Collaboration)
- Ghent University Hospital (Collaboration)
- Curie Institute Paris (Institut Curie) (Collaboration)
- University Hospitals Seidman Cancer Center (Collaboration)
- Leiden University (Collaboration)
- University of Copenhagen (Collaboration)
- University of Franche-Comté (Collaboration)
- Deakin University (Collaboration)
- Tulane Medical Center (Collaboration)
- University of East Anglia (Collaboration)
- UNIVERSITY OF CAMBRIDGE (Collaboration)
- Saint Michael's Hospital (Collaboration)
- UNIVERSITY OF EXETER (Collaboration)
- Radboud University Nijmegen Medical Center (Collaboration)
- University of Bern (Collaboration)
- Australian Institute of Family Studies (Collaboration)
- KING'S COLLEGE LONDON (Collaboration)
- Swiss Group for Cancer Clinical Research (SAKK) (Collaboration)
- Ann Arbor VA Medical Center (Collaboration)
- Royal Marsden NHS Foundation Trust (Collaboration)
- Albert Schweitzer Ziekenhuis (Collaboration)
- University of Padova (Collaboration)
- Kiel University (Collaboration)
- QUEEN MARY UNIVERSITY OF LONDON (Collaboration)
- AstraZeneca (Collaboration)
- UNIVERSITY OF EDINBURGH (Collaboration)
- University of Southern California (Collaboration)
- University Hospital Schleswig-Holstein (Collaboration)
- Fundación Marques de Valdecilla (Collaboration)
- University of Montreal (Collaboration)
- UNIVERSITY OF LEEDS (Collaboration)
- University of Bristol (Collaboration)
- UNIVERSITY OF LEICESTER (Collaboration)
- University of Gothenburg (Collaboration)
- Essen University Hospital (Collaboration)
- Regeneron Pharmaceuticals, Inc. (Collaboration)
- N.N. Alexandrov National Cancer Centre of Belarus (Collaboration)
- HEALTH DATA RESEARCH UK (Collaboration)
- California Pacific Medical Center (Collaboration)
- Cornell University (Collaboration)
- Peter MacCallum Cancer Centre (Collaboration)
- University of California (Collaboration)
- Copenhagen University Hospital (Collaboration)
- European Organisation for Research and Treatment of Cancer (EORTC) (Collaboration)
- University of Connecticut (Collaboration)
- Camden and Islington NHS Foundation Trust (Collaboration)
- Christus Health (Collaboration)
- University of Kyoto (Collaboration)
- THE CHRISTIE NHS FOUNDATION TRUST (Collaboration)
- Turku University Hospital (Collaboration)
- University of South Florida (Collaboration)
- Hebrew University of Jerusalem (Collaboration)
- University of Hong Kong (Collaboration)
- University Medical Center Utrecht (UMC) (Collaboration)
- Dana-Farber Cancer Institute (Collaboration)
- The University of Texas at San Antonio (Collaboration)
- University Medical Center Hamburg-Eppendorf (Collaboration)
- Flinders University (Collaboration)
- QUEEN'S UNIVERSITY BELFAST (Collaboration)
- Memorial Sloan Kettering Cancer Center (Collaboration)
- Hillingdon Hospital, Uxbridge (Collaboration)
- University of Melbourne (Collaboration)
- Tata Memorial Hospital (Collaboration)
- UNIVERSITY HOSPITALS BRISTOL AND WESTON NHS FOUNDATION TRUST (Collaboration)
- Northwestern University (Collaboration)
- Cambridgeshire and Peterborough NHS Foundation Trust (Collaboration)
- Antwerp University Hospital (Collaboration)
- Monash University (Collaboration)
- University of Michigan (Collaboration)
- Royal Marsden Hospital (Collaboration)
- Aix-Marseille University (Collaboration)
- Cleveland Clinic (Collaboration)
- University of Hasselt (Collaboration)
- North Carolina Institute of Medicine (Collaboration)
- National Cancer Centre Singapore (Collaboration)
- Brussels Saint-Luc University Hospital (UCL) (Collaboration)
- UNSW Sydney (Collaboration)
- Alexander Fleming Institute (Collaboration)
- Cantonal Hospital St. Gallen (Collaboration)
- University of Manchester (Collaboration)
- Queensland Government (Collaboration)
- University of Greifswald (Collaboration)
- Peking University (Collaboration)
- Université Catholique de Louvain (Collaboration)
- University of Malaya (Collaboration)
- University of Ioannina (Collaboration)
- Fred Hutchinson Cancer Research Center (FHCRC) (Collaboration)
- Centre Eugène Marquis (Collaboration)
- University of Würzburg (Collaboration)
Publications
Adams R
(2021)
Treatment breaks in first line treatment of advanced colorectal cancer: An individual patient data meta-analysis.
in Cancer treatment reviews
Advanced Bladder Cancer (ABC) Meta-Analysis Collaborators Group
(2022)
Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials.
in European urology
Al-Shahi Salman R
(2023)
Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials.
in The Lancet. Neurology
Al Wattar B
(2023)
Effectiveness of treatment options for tubal ectopic pregnancy: A systematic review and network meta-analysis
in BJOG: An International Journal of Obstetrics & Gynaecology
Buckman JEJ
(2021)
Is social support pre-treatment associated with prognosis for adults with depression in primary care?
in Acta psychiatrica Scandinavica
Buckman JEJ
(2023)
Predicting prognosis for adults with depression using individual symptom data: a comparison of modelling approaches.
in Psychological medicine
Buckman JEJ
(2021)
The contribution of depressive 'disorder characteristics' to determinations of prognosis for adults with depression: an individual patient data meta-analysis.
in Psychological medicine
Chiocchia V
(2023)
The complexity underlying treatment rankings: how to use them and what to look at.
in BMJ evidence-based medicine
Claxton L
(2022)
Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation
in Health Technology Assessment
Related Projects
| Project Reference | Relationship | Related To | Start | End | Award Value |
|---|---|---|---|---|---|
| MC_UU_00004/01 | 31/03/2021 | 30/03/2026 | £5,186,000 | ||
| MC_UU_00004/02 | Transfer | MC_UU_00004/01 | 31/03/2021 | 30/03/2026 | £4,446,000 |
| MC_UU_00004/03 | Transfer | MC_UU_00004/02 | 31/03/2021 | 30/03/2026 | £4,999,000 |
| MC_UU_00004/04 | Transfer | MC_UU_00004/03 | 31/03/2021 | 30/03/2026 | £5,315,000 |
| MC_UU_00004/05 | Transfer | MC_UU_00004/04 | 31/03/2021 | 30/03/2026 | £3,107,000 |
| MC_UU_00004/06 | Transfer | MC_UU_00004/05 | 31/03/2021 | 30/03/2026 | £2,889,000 |
| MC_UU_00004/07 | Transfer | MC_UU_00004/06 | 31/03/2021 | 30/03/2026 | £2,369,000 |
| MC_UU_00004/08 | Transfer | MC_UU_00004/07 | 31/03/2021 | 30/03/2026 | £2,270,000 |
| MC_UU_00004/09 | Transfer | MC_UU_00004/08 | 31/03/2021 | 30/03/2026 | £2,160,000 |
| Guideline Title | Covid Guidelines India |
| Description | Anti-IL6 COVID-19 SR (PMID:34228774) CMGIG guideline 2022 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline |
| Description | Anti-IL6 COVID-19 SR (PMID:34228774) ERS guideline 2022 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | IDSA Guidelines on the Treatment and Management of Patients with COVID-19 |
| Description | Anti-IL6 COVID-19 SR (PMID:34228774) IDSA guideline 2022 |
| Geographic Reach | North America |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Interim Clinical Commissioning Policy: IL-6 inhibitors (tocilizumab or sarilumab) for hospitalised patients with COVID-19 (adults) |
| Description | Anti-IL6 COVID-19 SR (PMID:34228774) NHS guideline 2022 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Therapeutics and COVID-19: Living Guideline. 6 July 2021 |
| Description | Anti-IL6 COVID-19 SR (PMID:34228774) WHO guideline 2021 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Therapeutics and COVID-19: Living Guideline. 18 August 2023 |
| Description | Anti-IL6 COVID-19 SR (PMID:34228774) WHO guideline 2023 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | EAU Guidelines on Bladder Cancer: Muscle-Invasive and Metastatic |
| Description | Bladder Adj CT IPD (PMID:15939530) EAU guideline 2021 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://uroweb.org/guideline/bladder-cancer-muscle-invasive-and-metastatic/ |
| Guideline Title | EAU Guidelines on Bladder Cancer: Muscle-Invasive and Metastatic Bladder cancer |
| Description | Bladder Adj CT IPD (PMID:15939530) EAU guideline 2022 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Clinical Practice Guidelines in Oncology - v.6.2021 Bladder Cancer |
| Description | Bladder Adj CT IPD (PMID:15939530) NCCN guideline 2021 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Clinical Practice Guidelines in Oncology - v.3.2022 Bladder Cancer |
| Description | Bladder Adj CT IPD (PMID:15939530) NCCN guideline 2022 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Clinical Practice Guidelines in Oncology - v.1.2024 Bladder Cancer |
| Description | Bladder Adj CT IPD (PMID:15939530) NCCN guideline 2024 |
| Geographic Reach | North America |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Clinical Practice Guideline GU-013 Version 8 (Muscle Invasive Bladder Cancer) (2021) |
| Description | Bladder Adj CT IPD (PMID:16625650) AHS guideline 2023 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | EAU Guidelines on Bladder Cancer: Muscle-Invasive and Metastatic Bladder cancer |
| Description | Bladder Adj CT IPD 2005 (PMID:15939530) EAU guideline 2023 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | EAU Guidelines on Bladder Cancer: Muscle-Invasive and Metastatic (2021) |
| Description | Bladder Neo CT IPD (PMID: 15939524) EAU guideline 2021 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://uroweb.org/guideline/bladder-cancer-muscle-invasive-and-metastatic/ |
| Guideline Title | EAU Guidelines on Bladder Cancer: Muscle-Invasive and Metastatic (2022) |
| Description | Bladder Neo CT IPD (PMID: 15939524) EAU guideline 2022 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up |
| Description | Bladder Neo CT IPD (PMID: 15939524) ESMO guideline 2021 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://www.esmo.org/guidelines/genitourinary-cancers/bladder-cancer |
| Guideline Title | NCCN Clinical Practice Guidelines in Oncology - Bladder Cancer Version 6.2021 |
| Description | Bladder Neo CT IPD (PMID: 15939524) NCCN guideline 2021 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Clinical Practice Guidelines in Oncology - Bladder Cancer Version 3.2022 |
| Description | Bladder Neo CT IPD (PMID: 15939524) NCCN guideline 2022 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Clinical Practice Guidelines in Oncology - Bladder Cancer Version 1.2024 |
| Description | Bladder Neo CT IPD (PMID: 15939524) NCCN guideline 2024 |
| Geographic Reach | North America |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Clinical Practice Guideline GU-013 Version 6 (Muscle Invasive Bladder Cancer) (2021) |
| Description | Bladder Neo CT IPD (PMID:15846746) AHS Guideline 2021 |
| Geographic Reach | North America |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Clinical Practice Guideline GU-013 Version 8 (Muscle Invasive Bladder Cancer) (2023) |
| Description | Bladder Neo CT IPD (PMID:15939524) AHS Guideline 2023 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | S3-Leitlinie Diagnostik, Therapie und Nachsorge der Patientin mit Zervixkarzinom v2.1 2021 |
| Description | Cervix CTRT IPD (PMID: 19001332) GGPO guideline 2021 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://www.awmf.org/uploads/tx_szleitlinien/032-033OLl_S3_Diagnostik_Therapie_Nachsorge_Zervixkarzi... |
| Guideline Title | S3-Leitlinie Diagnostik, Therapie und Nachsorge der Patientin mit Zervixkarzinom v2.1 2021 |
| Description | Cervix CTRT IPD (PMID: 19001332) GGPO guideline 2021 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://www.awmf.org/uploads/tx_szleitlinien/032-033OLl_S3_Diagnostik_Therapie_Nachsorge_Zervixkarzi... |
| Guideline Title | S3-Leitlinie Diagnostik, Therapie und Nachsorge der Patientin mit Zervixkarzinom v2.2 2022 |
| Description | Cervix CTRT IPD (PMID: 19001332) GGPO guideline 2022 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology - v.1.2022 Cervical Cancer |
| Description | Cervix CTRT IPD (PMID:19001332) NCCN guideline 2022 (1) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology - v.1.2023 Cervical Cancer |
| Description | Cervix CTRT IPD (PMID:19001332) NCCN guideline 2023 (1) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology - v.1 2024 Cervical Cancer |
| Description | Cervix CTRT IPD (PMID:19001332) NCCN guideline 2024 (1) |
| Geographic Reach | North America |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology - v.1.2022 Cervical Cancer |
| Description | Cervix CTRT IPD (PMID:20091632) NCCN guideline 2022 (1) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology - v.1.2023 Cervical Cancer |
| Description | Cervix CTRT IPD (PMID:20091632) NCCN guideline 2023 (1) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology - v.1.2024 Cervical Cancer |
| Description | Cervix CTRT IPD (PMID:20091632) NCCN guideline 2024 (1) |
| Geographic Reach | North America |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | S3-Leitlinie Diagnostik, Therapie und Nachsorge der Patientin mit Zervixkarzinom v2.2 2022 |
| Description | Cervix CTRT SR (PMID: 16034873) GGPO guideline 2022 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Management and Care of Patients With Invasive Cervical Cancer: ASCO Resource-Stratified Guideline Rapid Recommendation Update |
| Description | Cervix Neo CT IPD (PMID: 15106161) ASCO guideline 2022 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Cancer of the Uterine Cervix |
| Description | Cervix Neo CT SR (PMID:23235641) AHS guideline 2021 |
| Geographic Reach | North America |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-gyne004-cervical.pdf |
| Guideline Title | Management and Care of Patients With Invasive Cervical Cancer: ASCO Resource-Stratified Guideline Rapid Recommendation Update |
| Description | Cervix Neo CT SR (PMID:23235641) ASCO guideline 2022 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | S3-Leitlinie Diagnostik, Therapie und Nachsorge der Patientin mit Zervixkarzinom v2.1 2021 |
| Description | Cervix Neo CT SR (PMID:23235641) GGPO guideline 2021 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://www.awmf.org/uploads/tx_szleitlinien/032-033OLl_S3_Diagnostik_Therapie_Nachsorge_Zervixkarzi... |
| Guideline Title | S3-Leitlinie Diagnostik, Therapie und Nachsorge der Patientin mit Zervixkarzinom v2.2 2022 |
| Description | Cervix Neo CT SR (PMID:23235641) GGPO guideline 2022 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | S3-Leitlinie endometrriumkarzinom V2.0 (2022) |
| Description | Endometrial CT SR (PMID: 22895938) GGPO guideline 2022 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | S3-Leitlinie endometrriumkarzinom V3.01 (2023) |
| Description | Endometrial CT SR (PMID: 22895938) GGPO guideline 2023 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology v.1 2022. Uterine Neoplasms |
| Description | Endometrial CT SR (PMID:17150999) NCCN guideline 2022 (V1) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology v.1 2024. Uterine Neoplasms |
| Description | Endometrial CT SR (PMID:17150999) NCCN guideline 2024 (V1) |
| Geographic Reach | North America |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology v.1.2022. Non-Small Cell Lung Cancer |
| Description | Lung Adj CT IPD (PMID:20338628) NCCN guideline 2022 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology v.1.2023. Non-Small Cell Lung Cancer |
| Description | Lung Adj CT IPD (PMID:20338628) NCCN guideline 2023 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology v.2.2024. Non-Small Cell Lung Cancer |
| Description | Lung Adj CT IPD (PMID:20338628) NCCN guideline 2024 |
| Geographic Reach | North America |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I-IIIA Completely Resected Non-Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update |
| Description | Lung Adj CT IPD (PMID:25730344) ASCO guideline 2022 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I-IIIA Completely Resected Non-Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update |
| Description | Lung CT 95 IPD (PMID:7580546) ASCO guideline stage I-III NSCLC 2022 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative |
| Description | Lung CT 95 IPD (PMID:7580546) CSCO-ESMO guideline 2018 |
| Geographic Reach | Asia |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology v.1.2022. Non-Small Cell Lung Cancer |
| Description | Lung CT 95 IPD (PMID:7580546) NCCN guideline 2022 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Lung CT 95 IPD (PMID:7580546) NCCN guideline 2023 |
| Description | Lung CT 95 IPD (PMID:7580546) NCCN guideline 2023 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. V2.1 (2022) |
| Description | Lung Neo CT IPD (PMID: 24576776) GGPO guideline 2022 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. V3.01 (2023) |
| Description | Lung Neo CT IPD (PMID: 24576776) GGPO guideline 2023 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology v.1.2022. Non-Small Cell Lung Cancer |
| Description | Lung Neo CT IPD (PMID: 24576776) NCCN guideline 2022 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology v.1.2023. Non-Small Cell Lung Cancer |
| Description | Lung Neo CT IPD (PMID: 24576776) NCCN guideline 2023 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. V2.1 (2022) |
| Description | Lung PORT IPD (PMID: 9690404) GGPO guideline 2022 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. V3.01 (2023) |
| Description | Lung PORT IPD (PMID: 9690404) GGPO guideline 2023 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology v.1.2022. Non-Small Cell Lung Cancer |
| Description | Lung PORT IPD (PMID: 9690404) NCCN guideline 2022 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology v.1.2023. Non-Small Cell Lung Cancer |
| Description | Lung PORT IPD (PMID: 9690404) NCCN guideline 2023 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology v.2.2024. Non-Small Cell Lung Cancer |
| Description | Lung PORT IPD (PMID: 9690404) NCCN guideline 2024 |
| Geographic Reach | North America |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I-IIIA Completely Resected Non-Small-Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update |
| Description | Lung PORT IPD (PMID: 9690404; 23453644) ASCO guideline 2022 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. V2.1 (2022) |
| Description | Lung SC IPD (PMID: 18678835) GGPO guideline 2022 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. V3.01 (2024) |
| Description | Lung SC IPD (PMID: 18678835) GGPO guideline 2023 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology v.1.2022. Non-Small Cell Lung Cancer |
| Description | Lung SC IPD (PMID: 18678835) NCCN guideline 2022 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology v.1.2023. Non-Small Cell Lung Cancer |
| Description | Lung SC IPD (PMID: 18678835) NCCN guideline 2023 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. V2.1 (2022) |
| Description | Lung SC IPD (PMID: 25730344) GGPO guideline 2022 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. V3.01 (2023) |
| Description | Lung SC IPD (PMID: 25730344) GGPO guideline 2023 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative |
| Description | Lung SC IPD (PMID:18678835) CSCO-ESMO guideline 2018 |
| Geographic Reach | Asia |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. V2.1 (2022) |
| Description | Lung SeqCon CTRT IPD (PMID:20351327) GGPO guideline 2022 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. V3.01 (2023) |
| Description | Lung SeqCon CTRT IPD (PMID:20351327) GGPO guideline 2023 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology v1.2022. Non-Small Cell Lung Cancer |
| Description | Lung SeqCon CTRT IPD (PMID:20351327) NCCN guideline 2022 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology v1.2023. Non-Small Cell Lung Cancer |
| Description | Lung SeqCon CTRT IPD (PMID:20351327) NCCN guideline 2023 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology v2.2024. Non-Small Cell Lung Cancer |
| Description | Lung SeqCon CTRT IPD (PMID:20351327) NCCN guideline 2024 |
| Geographic Reach | North America |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Leitlinienprogramm onkologie. Diagnostik und therapie des Ösophaguskarzinoms v3.0 2021 |
| Description | Oesophagus RT IPD (PMID:16235286) GGPO guideline 2021 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://www.leitlinienprogramm-onkologie.de/leitlinien/oesophaguskarzinom/ |
| Guideline Title | Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus. V3.1 (2022) |
| Description | Oesophagus RT IPD (PMID:16235286) GGPO guideline 2022 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Leitlinie Diagnostik und Therapie der Plattenepithelkarzinome und Adenokarzinome des Ösophagus. V4.0 (2023) |
| Description | Oesophagus RT IPD (PMID:16235286) GGPO guideline 2023 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Guidelines Version 1.2022 Esophageal and Esophagogastric Junction Cancers |
| Description | Oesophagus RT IPD (PMID:9635705) NCCN guideline 2022 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Guidelines Version 5.2022 Esophageal and Esophagogastric Junction Cancers |
| Description | Oesophagus RT IPD (PMID:9635705) NCCN guideline 2022 (v5) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Guidelines Version 4.2023 Esophageal and Esophagogastric Junction Cancers |
| Description | Oesophagus RT IPD (PMID:9635705) NCCN guideline 2023 (v4) |
| Geographic Reach | North America |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | EAU Guideline: Prostate Cancer (2021) |
| Description | Prostate Abi AD (PMID: 28800492) EAU guideline 2021 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | EAU Guideline: Prostate Cancer (2022) |
| Description | Prostate Abi AD (PMID: 28800492) EAU guideline 2022 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | EAU Guideline: Prostate Cancer (2023) |
| Description | Prostate Abi AD (PMID: 28800492) EAU guideline 2023 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Local Prostate Cancer |
| Description | Prostate Artistic AD (PMID: 33002431) AHS guideline 2021 |
| Geographic Reach | North America |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://www.albertahealthservices.ca/assets/info/hp/cancer/if-hp-cancer-guide-gu012-local-prostate.p... |
| Guideline Title | Local Prostate Cancer |
| Description | Prostate Artistic AD (PMID: 33002431) AHS guideline 2022 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Clinically Localized Prostate Cancer: AUA/ASTRO Guideline (2022) |
| Description | Prostate Artistic AD (PMID: 33002431) AUA/ASTRO guideline 2022 |
| Geographic Reach | North America |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | EAU Guideline: Prostate Cancer (2021) |
| Description | Prostate Artistic AD (PMID: 33002431) EAU guideline 2021 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://uroweb.org/guideline/prostate-cancer/ |
| Guideline Title | EAU Guideline: Prostate Cancer (2022) |
| Description | Prostate Artistic AD (PMID: 33002431) EAU guideline 2022 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | EAU Guideline: Prostate Cancer (2023) |
| Description | Prostate Artistic AD (PMID: 33002431) EAU guideline 2023 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Leitlinie Prostatakarzinom v6.2 2021 |
| Description | Prostate Artistic AD (PMID: 33002431) GGPO guideline 2021 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://www.leitlinienprogramm-onkologie.de/leitlinien/prostatakarzinom/ |
| Guideline Title | NCCN Practice Guidelines in Oncology - v.2.2022 Prostate Cancer |
| Description | Prostate Artistic AD (PMID: 33002431) NCCN guideline 2021 V2 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology - v.1.2023 Prostate Cancer |
| Description | Prostate Artistic AD (PMID: 33002431) NCCN guideline 2023 V1 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology - v.4.2023 Prostate Cancer |
| Description | Prostate Artistic AD (PMID: 33002431) NCCN guideline 2023 V4 |
| Geographic Reach | North America |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Pan-Asian adapted ESMO Guidelines (2022) |
| Description | Prostate Artistic AD (PMID: 33002431) PAGA ESMO guideline 2022 |
| Geographic Reach | Asia |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | EAU Guideline: Prostate Cancer (2022) |
| Description | Prostate CT SR (PMID: 26718929) EAU guideline 2022 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | EAU Guideline: Prostate Cancer (2023) |
| Description | Prostate CT SR (PMID: 26718929) EAU guideline 2023 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Leitlinie Prostatakarzinom v6.2 2021 |
| Description | Prostate CT SR (PMID: 26718929) GGPO guideline 2021 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://www.leitlinienprogramm-onkologie.de/leitlinien/prostatakarzinom/ |
| Guideline Title | NCCN Practice Guidelines in Oncology - v.2.2022 Prostate Cancer |
| Description | Prostate CT SR (PMID: 26718929) NCCN guideline 2021 V2 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology - v.1.2023 Prostate Cancer |
| Description | Prostate CT SR (PMID: 26718929) NCCN guideline 2023 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Pan-Asian adapted ESMO Guidelines (2022) |
| Description | Prostate CT SR (PMID: 26718929) PAGA ESMO guideline 2022 |
| Geographic Reach | Asia |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology - v.1.2023 Prostate Cancer |
| Description | Prostate CT SR (PMID: 30826218) NCCN guideline 2023 |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Practice Guidelines in Oncology - v.4.2023 Prostate Cancer |
| Description | Prostate CT SR (PMID: 30826218) NCCN guideline 2023 v4 |
| Geographic Reach | North America |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | EAU Guideline: Prostate Cancer (2021) |
| Description | Prostate Network AD (PMID: 29788164) EAU guideline 2021 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://uroweb.org/guideline/prostate-cancer/ |
| Guideline Title | EAU Guideline: Prostate Cancer (2022) |
| Description | Prostate Network AD (PMID: 29788164) EAU guideline 2022 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | 2022 UPDATE: Canadian Urological Association-Canadian Urologic Oncology Group guideline: Metastatic castration-naive and castration-sensitive prostate cancer |
| Description | Prostate RT AD (PMID: 30826218) CUA guideline 2022 |
| Geographic Reach | National |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | EAU Guideline: Prostate Cancer (2021) |
| Description | Prostate RT AD (PMID: 30826218) EAU guideline 2021 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://uroweb.org/guideline/prostate-cancer/ |
| Guideline Title | EAU Guideline: Prostate Cancer (2022) |
| Description | Prostate RT AD (PMID: 30826218) EAU guideline 2022 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | EAU Guideline: Prostate Cancer (2023) |
| Description | Prostate RT AD (PMID: 30826218) EAU guideline 2023 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | Leitlinie Prostatakarzinom v6.2 2021 |
| Description | Prostate RT AD (PMID: 30826218) GGPO guideline 2021 |
| Geographic Reach | Europe |
| Policy Influence Type | Citation in clinical guidelines |
| URL | https://www.leitlinienprogramm-onkologie.de/leitlinien/prostatakarzinom/ |
| Guideline Title | NCCN Clinical Practice Guidelines in Oncology v2.2022 Soft Tissue Sarcoma |
| Description | Sarcoma CT IPD (PMID:9400508) NCCN guideline 2021 (V2) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Clinical Practice Guidelines in Oncology v3.2023 Soft Tissue Sarcoma |
| Description | Sarcoma CT IPD (PMID:9400508) NCCN guideline 2023 (V3) |
| Geographic Reach | North America |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Clinical Practice Guidelines in Oncology v.2.2021 Soft Tissue Sarcoma |
| Description | Sarcoma CT SR (PMID:7640234) NCCN guideline 2021 (V2) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Clinical Practice Guidelines in Oncology v.2.2022 Soft Tissue Sarcoma |
| Description | Sarcoma CT SR (PMID:7640234) NCCN guideline 2022 (V2) |
| Geographic Reach | Multiple continents/international |
| Policy Influence Type | Citation in clinical guidelines |
| Guideline Title | NCCN Clinical Practice Guidelines in Oncology v.3.2023 Soft Tissue Sarcoma |
| Description | Sarcoma CT SR (PMID:7640234) NCCN guideline 2023 (V3) |
| Geographic Reach | North America |
| Policy Influence Type | Citation in clinical guidelines |
| Description | NIHR Development and Skills Enhancement Award |
| Amount | £34,926 (GBP) |
| Funding ID | NIHR301653 |
| Organisation | National Institute for Health Research |
| Sector | Public |
| Country | United Kingdom |
| Start | 03/2021 |
| End | 03/2022 |
| Description | TMRP Doctoral Training Programme |
| Amount | £2,518,806 (GBP) |
| Organisation | Medical Research Council (MRC) |
| Sector | Public |
| Country | United Kingdom |
| Start | 08/2021 |
| End | 09/2026 |
| Description | Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials |
| Organisation | Circolo Hospital and Macchi Foundation |
| Country | Italy |
| Sector | Hospitals |
| PI Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript; critical revision of the manuscript for important intellectual content; administrative, technical, or material support; supervision |
| Collaborator Contribution | Study concept and design; provision of IPD; critical revision of the manuscript for important intellectual content and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 34802798) |
| Start Year | 2017 |
| Description | Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials |
| Organisation | European Organisation for Research and Treatment of Cancer (EORTC) |
| Country | Belgium |
| Sector | Charity/Non Profit |
| PI Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript; critical revision of the manuscript for important intellectual content; administrative, technical, or material support; supervision |
| Collaborator Contribution | Study concept and design; provision of IPD; critical revision of the manuscript for important intellectual content and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 34802798) |
| Start Year | 2017 |
| Description | Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials |
| Organisation | N.N. Alexandrov National Cancer Centre of Belarus |
| Country | Belarus |
| Sector | Private |
| PI Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript; critical revision of the manuscript for important intellectual content; administrative, technical, or material support; supervision |
| Collaborator Contribution | Study concept and design; provision of IPD; critical revision of the manuscript for important intellectual content and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 34802798) |
| Start Year | 2017 |
| Description | Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials |
| Organisation | NewYork-Presbyterian Hospital |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript; critical revision of the manuscript for important intellectual content; administrative, technical, or material support; supervision |
| Collaborator Contribution | Study concept and design; provision of IPD; critical revision of the manuscript for important intellectual content and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 34802798) |
| Start Year | 2017 |
| Description | Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials |
| Organisation | Saarland University |
| Country | Germany |
| Sector | Academic/University |
| PI Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript; critical revision of the manuscript for important intellectual content; administrative, technical, or material support; supervision |
| Collaborator Contribution | Study concept and design; provision of IPD; critical revision of the manuscript for important intellectual content and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 34802798) |
| Start Year | 2017 |
| Description | Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials |
| Organisation | Saint Louis University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript; critical revision of the manuscript for important intellectual content; administrative, technical, or material support; supervision |
| Collaborator Contribution | Study concept and design; provision of IPD; critical revision of the manuscript for important intellectual content and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 34802798) |
| Start Year | 2017 |
| Description | Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials |
| Organisation | Sapienza University of Rome |
| Country | Italy |
| Sector | Academic/University |
| PI Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript; critical revision of the manuscript for important intellectual content; administrative, technical, or material support; supervision |
| Collaborator Contribution | Study concept and design; provision of IPD; critical revision of the manuscript for important intellectual content and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 34802798) |
| Start Year | 2017 |
| Description | Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials |
| Organisation | The Christie NHS Foundation Trust |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript; critical revision of the manuscript for important intellectual content; administrative, technical, or material support; supervision |
| Collaborator Contribution | Study concept and design; provision of IPD; critical revision of the manuscript for important intellectual content and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 34802798) |
| Start Year | 2017 |
| Description | Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials |
| Organisation | University Hospital Erlangen |
| Country | Germany |
| Sector | Hospitals |
| PI Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript; critical revision of the manuscript for important intellectual content; administrative, technical, or material support; supervision |
| Collaborator Contribution | Study concept and design; provision of IPD; critical revision of the manuscript for important intellectual content and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 34802798) |
| Start Year | 2017 |
| Description | Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials |
| Organisation | University of Bern |
| Country | Switzerland |
| Sector | Academic/University |
| PI Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript; critical revision of the manuscript for important intellectual content; administrative, technical, or material support; supervision |
| Collaborator Contribution | Study concept and design; provision of IPD; critical revision of the manuscript for important intellectual content and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 34802798) |
| Start Year | 2017 |
| Description | Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials |
| Organisation | University of Connecticut |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript; critical revision of the manuscript for important intellectual content; administrative, technical, or material support; supervision |
| Collaborator Contribution | Study concept and design; provision of IPD; critical revision of the manuscript for important intellectual content and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 34802798) |
| Start Year | 2017 |
| Description | Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials |
| Organisation | University of Kiel |
| Country | Germany |
| Sector | Academic/University |
| PI Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript; critical revision of the manuscript for important intellectual content; administrative, technical, or material support; supervision |
| Collaborator Contribution | Study concept and design; provision of IPD; critical revision of the manuscript for important intellectual content and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 34802798) |
| Start Year | 2017 |
| Description | Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials |
| Organisation | University of Southern California |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript; critical revision of the manuscript for important intellectual content; administrative, technical, or material support; supervision |
| Collaborator Contribution | Study concept and design; provision of IPD; critical revision of the manuscript for important intellectual content and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 34802798) |
| Start Year | 2017 |
| Description | Aspirin after radical therapy for colorectal cancer: a prospective meta-analysis |
| Organisation | Antwerp University Hospital |
| Country | Belgium |
| Sector | Hospitals |
| PI Contribution | Conception; First drafts of protocol; Protocol finalisation and submission |
| Collaborator Contribution | Commenting on protocol |
| Impact | Protocol: PROSPERO CRD42023453156 |
| Start Year | 2021 |
| Description | Aspirin after radical therapy for colorectal cancer: a prospective meta-analysis |
| Organisation | Cantonal Hospital St. Gallen |
| Country | Switzerland |
| Sector | Hospitals |
| PI Contribution | Conception; First drafts of protocol; Protocol finalisation and submission |
| Collaborator Contribution | Commenting on protocol |
| Impact | Protocol: PROSPERO CRD42023453156 |
| Start Year | 2021 |
| Description | Aspirin after radical therapy for colorectal cancer: a prospective meta-analysis |
| Organisation | Karolinska Institute |
| Country | Sweden |
| Sector | Academic/University |
| PI Contribution | Conception; First drafts of protocol; Protocol finalisation and submission |
| Collaborator Contribution | Commenting on protocol |
| Impact | Protocol: PROSPERO CRD42023453156 |
| Start Year | 2021 |
| Description | Aspirin after radical therapy for colorectal cancer: a prospective meta-analysis |
| Organisation | Leiden University Medical Center |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | Conception; First drafts of protocol; Protocol finalisation and submission |
| Collaborator Contribution | Commenting on protocol |
| Impact | Protocol: PROSPERO CRD42023453156 |
| Start Year | 2021 |
| Description | Aspirin after radical therapy for colorectal cancer: a prospective meta-analysis |
| Organisation | National Cancer Centre Singapore |
| Country | Singapore |
| Sector | Hospitals |
| PI Contribution | Conception; First drafts of protocol; Protocol finalisation and submission |
| Collaborator Contribution | Commenting on protocol |
| Impact | Protocol: PROSPERO CRD42023453156 |
| Start Year | 2021 |
| Description | Aspirin after radical therapy for colorectal cancer: a prospective meta-analysis |
| Organisation | Oslo University Hospital |
| Country | Norway |
| Sector | Hospitals |
| PI Contribution | Conception; First drafts of protocol; Protocol finalisation and submission |
| Collaborator Contribution | Commenting on protocol |
| Impact | Protocol: PROSPERO CRD42023453156 |
| Start Year | 2021 |
| Description | Aspirin after radical therapy for colorectal cancer: a prospective meta-analysis |
| Organisation | Saitama Medical University |
| Country | Japan |
| Sector | Academic/University |
| PI Contribution | Conception; First drafts of protocol; Protocol finalisation and submission |
| Collaborator Contribution | Commenting on protocol |
| Impact | Protocol: PROSPERO CRD42023453156 |
| Start Year | 2021 |
| Description | Aspirin after radical therapy for colorectal cancer: a prospective meta-analysis |
| Organisation | Swiss Group for Cancer Clinical Research (SAKK) |
| Country | Switzerland |
| Sector | Academic/University |
| PI Contribution | Conception; First drafts of protocol; Protocol finalisation and submission |
| Collaborator Contribution | Commenting on protocol |
| Impact | Protocol: PROSPERO CRD42023453156 |
| Start Year | 2021 |
| Description | Aspirin after radical therapy for colorectal cancer: a prospective meta-analysis |
| Organisation | Tata Memorial Hospital |
| Country | India |
| Sector | Hospitals |
| PI Contribution | Conception; First drafts of protocol; Protocol finalisation and submission |
| Collaborator Contribution | Commenting on protocol |
| Impact | Protocol: PROSPERO CRD42023453156 |
| Start Year | 2021 |
| Description | Aspirin after radical therapy for colorectal cancer: a prospective meta-analysis |
| Organisation | University of Bern |
| Country | Switzerland |
| Sector | Academic/University |
| PI Contribution | Conception; First drafts of protocol; Protocol finalisation and submission |
| Collaborator Contribution | Commenting on protocol |
| Impact | Protocol: PROSPERO CRD42023453156 |
| Start Year | 2021 |
| Description | Aspirin after radical therapy for colorectal cancer: a prospective meta-analysis |
| Organisation | University of Glasgow |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Conception; First drafts of protocol; Protocol finalisation and submission |
| Collaborator Contribution | Commenting on protocol |
| Impact | Protocol: PROSPERO CRD42023453156 |
| Start Year | 2021 |
| Description | Aspirin after radical therapy for colorectal cancer: a prospective meta-analysis |
| Organisation | University of Sydney |
| Department | NHMRC Clinical Trials Centre |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Conception; First drafts of protocol; Protocol finalisation and submission |
| Collaborator Contribution | Commenting on protocol |
| Impact | Protocol: PROSPERO CRD42023453156 |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Albert Schweitzer Hospital |
| Country | Netherlands |
| Sector | Hospitals |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Ann Arbor VA Medical Center |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Beneficência Portuguesa de São Paulo |
| Country | Brazil |
| Sector | Charity/Non Profit |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Berry Consultants LLC |
| Country | United States |
| Sector | Private |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Genentech, Inc |
| Country | United States |
| Sector | Private |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Ghent University Hospital |
| Country | Belgium |
| Sector | Hospitals |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Guy's and St Thomas' NHS Foundation Trust |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Health Data Research UK |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Hebrew University of Jerusalem |
| Department | Hebrew University Hadassah Medical School |
| Country | Israel |
| Sector | Academic/University |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Hospital Ramón y Cajal |
| Country | Spain |
| Sector | Hospitals |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Hospital Reina Sofía de Córdoba |
| Country | Spain |
| Sector | Hospitals |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Hospital Universitario Puerta de Hierro |
| Country | Spain |
| Sector | Hospitals |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Hospital de Sant Pau |
| Country | Spain |
| Sector | Hospitals |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Imperial College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Karolinska University Hospital |
| Country | Sweden |
| Sector | Hospitals |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | King's College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Massachusetts General Hospital |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Massachusetts General Hospital |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Ministry of Health |
| Country | Malaysia |
| Sector | Public |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | National Institute of Health and Medical Research (INSERM) |
| Department | INSERM U1153 (Center for Epidemiology and Biostatistics) |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Necker-Enfants Malades Hospital |
| Country | France |
| Sector | Hospitals |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Public Assistance - Hospitals of Paris |
| Country | France |
| Sector | Hospitals |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Queen's Medical Center |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Regeneron Pharmaceuticals, Inc. |
| Country | United States |
| Sector | Private |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Sanofi |
| Department | Genzyme Corporation |
| Country | United States |
| Sector | Private |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | Turku University Hospital |
| Country | Finland |
| Sector | Hospitals |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | University Hospital La Princesa |
| Country | Spain |
| Sector | Hospitals |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | University Hospital of Valme |
| Country | Spain |
| Sector | Hospitals |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | University Hospitals Bristol and Weston NHS Foundation Trust |
| Country | United Kingdom |
| Sector | Hospitals |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | University Medical Center Utrecht (UMC) |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | University of Bristol |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | University of British Columbia |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | University of Chicago Medical Center |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | University of Groningen |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | University of Malaya |
| Country | Malaysia |
| Sector | Academic/University |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | University of Melbourne |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | University of Oxford |
| Department | Nuffield Department of Population Health |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | University of Paris |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | University of Toronto |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis |
| Organisation | World Health Organization (WHO) |
| Country | Global |
| Sector | Public |
| PI Contribution | Concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript and critical revision of the manuscript |
| Collaborator Contribution | Obtained funding, concept and design, acquisition, analysis, or interpretation of data, statistical analysis, drafting of the manuscript, critical revision of the manuscript, administrative, technical, or material support and supervision |
| Impact | 1 protocol, and 1 paper (PMID: 35076012), 1 guideline |
| Start Year | 2021 |
| Description | Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review |
| Organisation | Barts Health NHS Trust |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Design of the review; advised on methodology and contributed to and approved the final manuscript |
| Collaborator Contribution | Design of the review; wrote the protocol; undertook literature review and analysis; devised the strategies for database searches and contributed to and approved the final manuscript |
| Impact | 1 protocol, and 1 paper (PMID: 34404753) |
| Start Year | 2018 |
| Description | Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review |
| Organisation | King's College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Design of the review; advised on methodology and contributed to and approved the final manuscript |
| Collaborator Contribution | Design of the review; wrote the protocol; undertook literature review and analysis; devised the strategies for database searches and contributed to and approved the final manuscript |
| Impact | 1 protocol, and 1 paper (PMID: 34404753) |
| Start Year | 2018 |
| Description | Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review |
| Organisation | Queen Mary University of London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Design of the review; advised on methodology and contributed to and approved the final manuscript |
| Collaborator Contribution | Design of the review; wrote the protocol; undertook literature review and analysis; devised the strategies for database searches and contributed to and approved the final manuscript |
| Impact | 1 protocol, and 1 paper (PMID: 34404753) |
| Start Year | 2018 |
| Description | Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review |
| Organisation | University College London |
| Department | Lungs for Living Research Centre |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Design of the review; advised on methodology and contributed to and approved the final manuscript |
| Collaborator Contribution | Design of the review; wrote the protocol; undertook literature review and analysis; devised the strategies for database searches and contributed to and approved the final manuscript |
| Impact | 1 protocol, and 1 paper (PMID: 34404753) |
| Start Year | 2018 |
| Description | Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review |
| Organisation | University of Leicester |
| Department | Respiratory Medicine |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Design of the review; advised on methodology and contributed to and approved the final manuscript |
| Collaborator Contribution | Design of the review; wrote the protocol; undertook literature review and analysis; devised the strategies for database searches and contributed to and approved the final manuscript |
| Impact | 1 protocol, and 1 paper (PMID: 34404753) |
| Start Year | 2018 |
| Description | Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation |
| Organisation | Pumping Marvellous Foundation |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Member of the Project Advisory Group, provided feedback and advice during the project, and commented on the final report. |
| Collaborator Contribution | Development of the protocol, economic analysis and the statistical analysis plan. Performed all database searches, provided oversight of data extraction and quality assessment the analyses, provided data and information about the data and contributed to the writing of all sections of the report |
| Impact | 1 protocol, and 1 paper (PMID: 35076012) |
| Start Year | 2018 |
| Description | Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation |
| Organisation | Somerset NHS Foundation Trust |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Member of the Project Advisory Group, provided feedback and advice during the project, and commented on the final report. |
| Collaborator Contribution | Development of the protocol, economic analysis and the statistical analysis plan. Performed all database searches, provided oversight of data extraction and quality assessment the analyses, provided data and information about the data and contributed to the writing of all sections of the report |
| Impact | 1 protocol, and 1 paper (PMID: 35076012) |
| Start Year | 2018 |
| Description | Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation |
| Organisation | University of Leeds |
| Department | Leeds School of Medicine |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Member of the Project Advisory Group, provided feedback and advice during the project, and commented on the final report. |
| Collaborator Contribution | Development of the protocol, economic analysis and the statistical analysis plan. Performed all database searches, provided oversight of data extraction and quality assessment the analyses, provided data and information about the data and contributed to the writing of all sections of the report |
| Impact | 1 protocol, and 1 paper (PMID: 35076012) |
| Start Year | 2018 |
| Description | Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation |
| Organisation | University of Maryland |
| Department | School of Medicine Maryland |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Member of the Project Advisory Group, provided feedback and advice during the project, and commented on the final report. |
| Collaborator Contribution | Development of the protocol, economic analysis and the statistical analysis plan. Performed all database searches, provided oversight of data extraction and quality assessment the analyses, provided data and information about the data and contributed to the writing of all sections of the report |
| Impact | 1 protocol, and 1 paper (PMID: 35076012) |
| Start Year | 2018 |
| Description | Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation |
| Organisation | University of York |
| Department | Centre for Reviews and Dissemination (CRD) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Member of the Project Advisory Group, provided feedback and advice during the project, and commented on the final report. |
| Collaborator Contribution | Development of the protocol, economic analysis and the statistical analysis plan. Performed all database searches, provided oversight of data extraction and quality assessment the analyses, provided data and information about the data and contributed to the writing of all sections of the report |
| Impact | 1 protocol, and 1 paper (PMID: 35076012) |
| Start Year | 2018 |
| Description | Collaboration Of Controlled Randomised trials of long-term Oral Antithrombotic agents after spontaneous intraCranial Haemorrhage (COCROACH): Individual Participant Data Meta-Analysis |
| Organisation | Akershus University Hospital |
| Country | Norway |
| Sector | Hospitals |
| PI Contribution | Advising on practical and methodological aspects including commenting on the protocol and SAP. |
| Collaborator Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript |
| Impact | 1 protocol and 1 SAP |
| Start Year | 2017 |
| Description | Collaboration Of Controlled Randomised trials of long-term Oral Antithrombotic agents after spontaneous intraCranial Haemorrhage (COCROACH): Individual Participant Data Meta-Analysis |
| Organisation | Albert Schweitzer Hospital |
| Country | Netherlands |
| Sector | Hospitals |
| PI Contribution | Advising on practical and methodological aspects including commenting on the protocol and SAP. |
| Collaborator Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript |
| Impact | 1 protocol and 1 SAP |
| Start Year | 2017 |
| Description | Collaboration Of Controlled Randomised trials of long-term Oral Antithrombotic agents after spontaneous intraCranial Haemorrhage (COCROACH): Individual Participant Data Meta-Analysis |
| Organisation | Cornell University |
| Department | Weill Cornell Medicine |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Advising on practical and methodological aspects including commenting on the protocol and SAP. |
| Collaborator Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript |
| Impact | 1 protocol and 1 SAP |
| Start Year | 2017 |
| Description | Collaboration Of Controlled Randomised trials of long-term Oral Antithrombotic agents after spontaneous intraCranial Haemorrhage (COCROACH): Individual Participant Data Meta-Analysis |
| Organisation | Fudan University |
| Country | China |
| Sector | Academic/University |
| PI Contribution | Advising on practical and methodological aspects including commenting on the protocol and SAP. |
| Collaborator Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript |
| Impact | 1 protocol and 1 SAP |
| Start Year | 2017 |
| Description | Collaboration Of Controlled Randomised trials of long-term Oral Antithrombotic agents after spontaneous intraCranial Haemorrhage (COCROACH): Individual Participant Data Meta-Analysis |
| Organisation | George Institute for Global Health |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Advising on practical and methodological aspects including commenting on the protocol and SAP. |
| Collaborator Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript |
| Impact | 1 protocol and 1 SAP |
| Start Year | 2017 |
| Description | Collaboration Of Controlled Randomised trials of long-term Oral Antithrombotic agents after spontaneous intraCranial Haemorrhage (COCROACH): Individual Participant Data Meta-Analysis |
| Organisation | Imperial College London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Advising on practical and methodological aspects including commenting on the protocol and SAP. |
| Collaborator Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript |
| Impact | 1 protocol and 1 SAP |
| Start Year | 2017 |
| Description | Collaboration Of Controlled Randomised trials of long-term Oral Antithrombotic agents after spontaneous intraCranial Haemorrhage (COCROACH): Individual Participant Data Meta-Analysis |
| Organisation | McMaster University |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Advising on practical and methodological aspects including commenting on the protocol and SAP. |
| Collaborator Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript |
| Impact | 1 protocol and 1 SAP |
| Start Year | 2017 |
| Description | Collaboration Of Controlled Randomised trials of long-term Oral Antithrombotic agents after spontaneous intraCranial Haemorrhage (COCROACH): Individual Participant Data Meta-Analysis |
| Organisation | Peking University |
| Country | China |
| Sector | Academic/University |
| PI Contribution | Advising on practical and methodological aspects including commenting on the protocol and SAP. |
| Collaborator Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript |
| Impact | 1 protocol and 1 SAP |
| Start Year | 2017 |
| Description | Collaboration Of Controlled Randomised trials of long-term Oral Antithrombotic agents after spontaneous intraCranial Haemorrhage (COCROACH): Individual Participant Data Meta-Analysis |
| Organisation | Radboud University Nijmegen Medical Center |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | Advising on practical and methodological aspects including commenting on the protocol and SAP. |
| Collaborator Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript |
| Impact | 1 protocol and 1 SAP |
| Start Year | 2017 |
| Description | Collaboration Of Controlled Randomised trials of long-term Oral Antithrombotic agents after spontaneous intraCranial Haemorrhage (COCROACH): Individual Participant Data Meta-Analysis |
| Organisation | Umea University |
| Country | Sweden |
| Sector | Academic/University |
| PI Contribution | Advising on practical and methodological aspects including commenting on the protocol and SAP. |
| Collaborator Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript |
| Impact | 1 protocol and 1 SAP |
| Start Year | 2017 |
| Description | Collaboration Of Controlled Randomised trials of long-term Oral Antithrombotic agents after spontaneous intraCranial Haemorrhage (COCROACH): Individual Participant Data Meta-Analysis |
| Organisation | University of British Columbia |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Advising on practical and methodological aspects including commenting on the protocol and SAP. |
| Collaborator Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript |
| Impact | 1 protocol and 1 SAP |
| Start Year | 2017 |
| Description | Collaboration Of Controlled Randomised trials of long-term Oral Antithrombotic agents after spontaneous intraCranial Haemorrhage (COCROACH): Individual Participant Data Meta-Analysis |
| Organisation | University of Copenhagen |
| Country | Denmark |
| Sector | Academic/University |
| PI Contribution | Advising on practical and methodological aspects including commenting on the protocol and SAP. |
| Collaborator Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript |
| Impact | 1 protocol and 1 SAP |
| Start Year | 2017 |
| Description | Collaboration Of Controlled Randomised trials of long-term Oral Antithrombotic agents after spontaneous intraCranial Haemorrhage (COCROACH): Individual Participant Data Meta-Analysis |
| Organisation | University of Côte d'Azur |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Advising on practical and methodological aspects including commenting on the protocol and SAP. |
| Collaborator Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript |
| Impact | 1 protocol and 1 SAP |
| Start Year | 2017 |
| Description | Collaboration Of Controlled Randomised trials of long-term Oral Antithrombotic agents after spontaneous intraCranial Haemorrhage (COCROACH): Individual Participant Data Meta-Analysis |
| Organisation | University of Edinburgh |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Advising on practical and methodological aspects including commenting on the protocol and SAP. |
| Collaborator Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript |
| Impact | 1 protocol and 1 SAP |
| Start Year | 2017 |
| Description | Collaboration Of Controlled Randomised trials of long-term Oral Antithrombotic agents after spontaneous intraCranial Haemorrhage (COCROACH): Individual Participant Data Meta-Analysis |
| Organisation | University of Lille |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Advising on practical and methodological aspects including commenting on the protocol and SAP. |
| Collaborator Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript |
| Impact | 1 protocol and 1 SAP |
| Start Year | 2017 |
| Description | Collaboration Of Controlled Randomised trials of long-term Oral Antithrombotic agents after spontaneous intraCranial Haemorrhage (COCROACH): Individual Participant Data Meta-Analysis |
| Organisation | University of Twente |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | Advising on practical and methodological aspects including commenting on the protocol and SAP. |
| Collaborator Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript |
| Impact | 1 protocol and 1 SAP |
| Start Year | 2017 |
| Description | Collaboration Of Controlled Randomised trials of long-term Oral Antithrombotic agents after spontaneous intraCranial Haemorrhage (COCROACH): Individual Participant Data Meta-Analysis |
| Organisation | University of Western Australia |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Advising on practical and methodological aspects including commenting on the protocol and SAP. |
| Collaborator Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript |
| Impact | 1 protocol and 1 SAP |
| Start Year | 2017 |
| Description | Collaboration Of Controlled Randomised trials of long-term Oral Antithrombotic agents after spontaneous intraCranial Haemorrhage (COCROACH): Individual Participant Data Meta-Analysis |
| Organisation | University of Wurzburg |
| Country | Germany |
| Sector | Academic/University |
| PI Contribution | Advising on practical and methodological aspects including commenting on the protocol and SAP. |
| Collaborator Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript |
| Impact | 1 protocol and 1 SAP |
| Start Year | 2017 |
| Description | Collaboration Of Controlled Randomised trials of long-term Oral Antithrombotic agents after spontaneous intraCranial Haemorrhage (COCROACH): Individual Participant Data Meta-Analysis |
| Organisation | Yale University |
| Department | School of Medicine |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Advising on practical and methodological aspects including commenting on the protocol and SAP. |
| Collaborator Contribution | Study concept and design; acquisition of data; analysis and interpretation of data; statistical analysis; drafting of the manuscript |
| Impact | 1 protocol and 1 SAP |
| Start Year | 2017 |
| Description | Dealing with Missing Data in an IPD Meta-analysis (Chapter 18). In: Individual participant data meta-analysis: A handbook for healthcare research |
| Organisation | Maastricht University (UM) |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | Co-authored the chapter |
| Collaborator Contribution | Co-authored the chapter. One partner led writing the chapter and one was co-editor of book |
| Impact | 1 book chapter (Chapter 18) |
| Start Year | 2015 |
| Description | Dealing with Missing Data in an IPD Meta-analysis (Chapter 18). In: Individual participant data meta-analysis: A handbook for healthcare research |
| Organisation | University Medical Center Utrecht (UMC) |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | Co-authored the chapter |
| Collaborator Contribution | Co-authored the chapter. One partner led writing the chapter and one was co-editor of book |
| Impact | 1 book chapter (Chapter 18) |
| Start Year | 2015 |
| Description | Development of a checklist of standard items for processing individual participant data from randomised trials for meta-analyses: protocol for a modified e-Delphi study |
| Organisation | Deakin University |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Members of the research team contributed to the design of the protocol, commented on drafts and advised on the scoping review |
| Collaborator Contribution | Conceptualised design of study, gained funding, developed and drafted protocol. Carried out scoping review |
| Impact | 1 protocol, and 1 paper (PMID: 36219622) |
| Start Year | 2021 |
| Description | Development of a checklist of standard items for processing individual participant data from randomised trials for meta-analyses: protocol for a modified e-Delphi study |
| Organisation | Monash University |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Members of the research team contributed to the design of the protocol, commented on drafts and advised on the scoping review |
| Collaborator Contribution | Conceptualised design of study, gained funding, developed and drafted protocol. Carried out scoping review |
| Impact | 1 protocol, and 1 paper (PMID: 36219622) |
| Start Year | 2021 |
| Description | Development of a checklist of standard items for processing individual participant data from randomised trials for meta-analyses: protocol for a modified e-Delphi study |
| Organisation | Queen's University Belfast |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Members of the research team contributed to the design of the protocol, commented on drafts and advised on the scoping review |
| Collaborator Contribution | Conceptualised design of study, gained funding, developed and drafted protocol. Carried out scoping review |
| Impact | 1 protocol, and 1 paper (PMID: 36219622) |
| Start Year | 2021 |
| Description | Development of a checklist of standard items for processing individual participant data from randomised trials for meta-analyses: protocol for a modified e-Delphi study |
| Organisation | University of Sydney |
| Department | NHMRC Clinical Trials Centre |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Members of the research team contributed to the design of the protocol, commented on drafts and advised on the scoping review |
| Collaborator Contribution | Conceptualised design of study, gained funding, developed and drafted protocol. Carried out scoping review |
| Impact | 1 protocol, and 1 paper (PMID: 36219622) |
| Start Year | 2021 |
| Description | Efficacy and moderators of efficacy of trauma-focused cognitive behavioural therapies in children and adolescents: protocol for an individual participant data meta-analysis from randomised trials |
| Organisation | Cambridgeshire and Peterborough NHS Foundation Trust |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Contributed to study methods; critically reviewed and approved the final manuscript |
| Collaborator Contribution | Designed the project; critically reviewed and approved the final manuscript. |
| Impact | Protocol - PROSPERO CRD42019151954 Publication of Protocol - doi: 10.1136/bmjopen-2020-047212 |
| Start Year | 2020 |
| Description | Efficacy and moderators of efficacy of trauma-focused cognitive behavioural therapies in children and adolescents: protocol for an individual participant data meta-analysis from randomised trials |
| Organisation | University Children's Hospital Zurich |
| Country | Switzerland |
| Sector | Hospitals |
| PI Contribution | Contributed to study methods; critically reviewed and approved the final manuscript |
| Collaborator Contribution | Designed the project; critically reviewed and approved the final manuscript. |
| Impact | Protocol - PROSPERO CRD42019151954 Publication of Protocol - doi: 10.1136/bmjopen-2020-047212 |
| Start Year | 2020 |
| Description | Efficacy and moderators of efficacy of trauma-focused cognitive behavioural therapies in children and adolescents: protocol for an individual participant data meta-analysis from randomised trials |
| Organisation | University of Cambridge |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Contributed to study methods; critically reviewed and approved the final manuscript |
| Collaborator Contribution | Designed the project; critically reviewed and approved the final manuscript. |
| Impact | Protocol - PROSPERO CRD42019151954 Publication of Protocol - doi: 10.1136/bmjopen-2020-047212 |
| Start Year | 2020 |
| Description | Efficacy and moderators of efficacy of trauma-focused cognitive behavioural therapies in children and adolescents: protocol for an individual participant data meta-analysis from randomised trials |
| Organisation | University of East Anglia |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Contributed to study methods; critically reviewed and approved the final manuscript |
| Collaborator Contribution | Designed the project; critically reviewed and approved the final manuscript. |
| Impact | Protocol - PROSPERO CRD42019151954 Publication of Protocol - doi: 10.1136/bmjopen-2020-047212 |
| Start Year | 2020 |
| Description | Efficacy and moderators of efficacy of trauma-focused cognitive behavioural therapies in children and adolescents: protocol for an individual participant data meta-analysis from randomised trials |
| Organisation | University of Zurich |
| Country | Switzerland |
| Sector | Academic/University |
| PI Contribution | Contributed to study methods; critically reviewed and approved the final manuscript |
| Collaborator Contribution | Designed the project; critically reviewed and approved the final manuscript. |
| Impact | Protocol - PROSPERO CRD42019151954 Publication of Protocol - doi: 10.1136/bmjopen-2020-047212 |
| Start Year | 2020 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | Australian Institute of Family Studies |
| Country | Australia |
| Sector | Public |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | Baylor College of Medicine |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | California Pacific Medical Center |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | Catholic University of Louvain |
| Country | Belgium |
| Sector | Academic/University |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | Fiona Stanley Hospital |
| Country | Australia |
| Sector | Hospitals |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | Flinders University |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | Harvard University |
| Department | Harvard Medical School |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | Johns Hopkins University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | Monash University |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | Oregon Health and Science University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | Sahlgrenska University Hospital |
| Country | Sweden |
| Sector | Hospitals |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | Skåne University Hospital |
| Country | Sweden |
| Sector | Academic/University |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | University of Adelaide |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | University of California, San Francisco |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | University of Gothenburg |
| Country | Sweden |
| Sector | Academic/University |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | University of Greifswald |
| Country | Germany |
| Sector | Academic/University |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | University of Manchester |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | University of New South Wales |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | University of North Carolina at Chapel Hill |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | University of Sydney |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | University of Washington |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | Factors associated with circulating sex hormones in men : individual participant data meta-analyses |
| Organisation | University of Western Australia |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Analysis and interpretation of the data; Statistical expertise; Final approval of the article |
| Collaborator Contribution | Conception and design; Analysis and interpretation of the data; Drafting of the article; Critical revision for important intellectual content; Final approval of the article; Provision of study materials or patients; Statistical expertise; Obtaining of funding; Administrative, technical, or logistic support; Collection and assembly of data. |
| Impact | Protocol: PROSPERO CRD42019139668 Publication: https://doi.org/10.7326/M23-0342 |
| Start Year | 2021 |
| Description | IW advisor to Orestis Efthimiou grant |
| Organisation | University of Bern |
| Country | Switzerland |
| Sector | Academic/University |
| PI Contribution | Advised on development and submission of successful research grant proposal to Swiss National Science Foundation (SNSF). Collaborated on two papers. |
| Collaborator Contribution | Developed and submitted successful research grant proposal to Swiss National Science Foundation (SNSF). Collaborated on two papers. |
| Impact | Two papers published so far. |
| Start Year | 2017 |
| Description | IW collaborator on SNSF grant, PI Georgia Salanti |
| Organisation | University of Bern |
| Country | Switzerland |
| Sector | Academic/University |
| PI Contribution | Advised on development and submission of successful grant application to SNF. Collaborating on papers. |
| Collaborator Contribution | Developed and submitted successful grant application to SNF. Collaborating on papers. |
| Impact | Multi-disciplinary - epidemiology, systematic review, biostatistics. One publication on treatment hierarchy question. Future impact on conduct of network meta-analysis. |
| Start Year | 2017 |
| Description | IW in ROBIS-NMA group |
| Organisation | University of Bristol |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Contributed expertise in network meta-analysis |
| Collaborator Contribution | Contributed expertise in systematic review and network meta-analysis |
| Impact | Multidisciplinary work - systematic review and biostatistics. Current outputs - two publications on methods for developing the tool. Future outputs - tool for evaluating risk of bias in a network meta-analysis, expected impact on use of network meta-analysis in health policy making |
| Start Year | 2020 |
| Description | IW in ROBIS-NMA group |
| Organisation | University of Toronto |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Contributed expertise in network meta-analysis |
| Collaborator Contribution | Contributed expertise in systematic review and network meta-analysis |
| Impact | Multidisciplinary work - systematic review and biostatistics. Current outputs - two publications on methods for developing the tool. Future outputs - tool for evaluating risk of bias in a network meta-analysis, expected impact on use of network meta-analysis in health policy making |
| Start Year | 2020 |
| Description | Incorporating dose effects in network meta-analysis |
| Organisation | AstraZeneca |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Contributed to the conception and design of this study, and to the manuscript's revision and interpretation of findings |
| Collaborator Contribution | Conceived the study idea, contributed to the study design, developed model codes, prepared datasets, completed analyses, contributed to interpretation of findings, drafted the initial manuscript, provided manuscript feedback and integrated co-author feedback |
| Impact | 1 paper (PMID: 35042687) |
| Start Year | 2016 |
| Description | Incorporating dose effects in network meta-analysis |
| Organisation | Saint Michael's Hospital |
| Country | Canada |
| Sector | Hospitals |
| PI Contribution | Contributed to the conception and design of this study, and to the manuscript's revision and interpretation of findings |
| Collaborator Contribution | Conceived the study idea, contributed to the study design, developed model codes, prepared datasets, completed analyses, contributed to interpretation of findings, drafted the initial manuscript, provided manuscript feedback and integrated co-author feedback |
| Impact | 1 paper (PMID: 35042687) |
| Start Year | 2016 |
| Description | Incorporating dose effects in network meta-analysis |
| Organisation | University of Bern |
| Country | Switzerland |
| Sector | Academic/University |
| PI Contribution | Contributed to the conception and design of this study, and to the manuscript's revision and interpretation of findings |
| Collaborator Contribution | Conceived the study idea, contributed to the study design, developed model codes, prepared datasets, completed analyses, contributed to interpretation of findings, drafted the initial manuscript, provided manuscript feedback and integrated co-author feedback |
| Impact | 1 paper (PMID: 35042687) |
| Start Year | 2016 |
| Description | Incorporating dose effects in network meta-analysis |
| Organisation | University of Ioannina |
| Country | Greece |
| Sector | Academic/University |
| PI Contribution | Contributed to the conception and design of this study, and to the manuscript's revision and interpretation of findings |
| Collaborator Contribution | Conceived the study idea, contributed to the study design, developed model codes, prepared datasets, completed analyses, contributed to interpretation of findings, drafted the initial manuscript, provided manuscript feedback and integrated co-author feedback |
| Impact | 1 paper (PMID: 35042687) |
| Start Year | 2016 |
| Description | Incorporating dose effects in network meta-analysis |
| Organisation | University of Toronto |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Contributed to the conception and design of this study, and to the manuscript's revision and interpretation of findings |
| Collaborator Contribution | Conceived the study idea, contributed to the study design, developed model codes, prepared datasets, completed analyses, contributed to interpretation of findings, drafted the initial manuscript, provided manuscript feedback and integrated co-author feedback |
| Impact | 1 paper (PMID: 35042687) |
| Start Year | 2016 |
| Description | Individual participant data meta-analysis: A handbook for healthcare research (whole book) |
| Organisation | Keele University |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Co-editor. Conceived the book concept and planned the outline. Co-authored multiple chapters |
| Collaborator Contribution | Co-editors. Conceived the book concept and planned the outline. Co-authored multiple chapters |
| Impact | 1 book [ISBN: 978-1-119-33372-2] |
| Start Year | 2015 |
| Description | Individual participant data meta-analysis: A handbook for healthcare research (whole book) |
| Organisation | University of York |
| Department | Centre for Reviews and Dissemination (CRD) |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Co-editor. Conceived the book concept and planned the outline. Co-authored multiple chapters |
| Collaborator Contribution | Co-editors. Conceived the book concept and planned the outline. Co-authored multiple chapters |
| Impact | 1 book [ISBN: 978-1-119-33372-2] |
| Start Year | 2015 |
| Description | Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis |
| Organisation | Guy's and St Thomas' NHS Foundation Trust |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Study conception and design and planned the statistical analyses; accessed, verified and analysed the data; wrote the first draft of the manuscript; commented on the drafts and approved the final draft |
| Collaborator Contribution | Study conception and design and planned the statistical analyses; collected data and did quality assessment; critically revised the manuscript; commented on the drafts and approved the final draft |
| Impact | 1 protocol, and 1 paper (PMID: 34171281) |
| Start Year | 2018 |
| Description | Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis |
| Organisation | Hospital Ramón y Cajal |
| Country | Spain |
| Sector | Hospitals |
| PI Contribution | Study conception and design and planned the statistical analyses; accessed, verified and analysed the data; wrote the first draft of the manuscript; commented on the drafts and approved the final draft |
| Collaborator Contribution | Study conception and design and planned the statistical analyses; collected data and did quality assessment; critically revised the manuscript; commented on the drafts and approved the final draft |
| Impact | 1 protocol, and 1 paper (PMID: 34171281) |
| Start Year | 2018 |
| Description | Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis |
| Organisation | Institute of Health Carlos III |
| Country | Spain |
| Sector | Public |
| PI Contribution | Study conception and design and planned the statistical analyses; accessed, verified and analysed the data; wrote the first draft of the manuscript; commented on the drafts and approved the final draft |
| Collaborator Contribution | Study conception and design and planned the statistical analyses; collected data and did quality assessment; critically revised the manuscript; commented on the drafts and approved the final draft |
| Impact | 1 protocol, and 1 paper (PMID: 34171281) |
| Start Year | 2018 |
| Description | Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis |
| Organisation | Monash University |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Study conception and design and planned the statistical analyses; accessed, verified and analysed the data; wrote the first draft of the manuscript; commented on the drafts and approved the final draft |
| Collaborator Contribution | Study conception and design and planned the statistical analyses; collected data and did quality assessment; critically revised the manuscript; commented on the drafts and approved the final draft |
| Impact | 1 protocol, and 1 paper (PMID: 34171281) |
| Start Year | 2018 |
| Description | Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis |
| Organisation | Queen Mary University of London |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Study conception and design and planned the statistical analyses; accessed, verified and analysed the data; wrote the first draft of the manuscript; commented on the drafts and approved the final draft |
| Collaborator Contribution | Study conception and design and planned the statistical analyses; collected data and did quality assessment; critically revised the manuscript; commented on the drafts and approved the final draft |
| Impact | 1 protocol, and 1 paper (PMID: 34171281) |
| Start Year | 2018 |
| Description | Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis |
| Organisation | University of Birmingham |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Study conception and design and planned the statistical analyses; accessed, verified and analysed the data; wrote the first draft of the manuscript; commented on the drafts and approved the final draft |
| Collaborator Contribution | Study conception and design and planned the statistical analyses; collected data and did quality assessment; critically revised the manuscript; commented on the drafts and approved the final draft |
| Impact | 1 protocol, and 1 paper (PMID: 34171281) |
| Start Year | 2018 |
| Description | Iron preparations for women of reproductive age with iron deficiency anaemia in pregnancy (FRIDA): a systematic review and network meta-analysis |
| Organisation | University of Granada |
| Country | Spain |
| Sector | Academic/University |
| PI Contribution | Study conception and design and planned the statistical analyses; accessed, verified and analysed the data; wrote the first draft of the manuscript; commented on the drafts and approved the final draft |
| Collaborator Contribution | Study conception and design and planned the statistical analyses; collected data and did quality assessment; critically revised the manuscript; commented on the drafts and approved the final draft |
| Impact | 1 protocol, and 1 paper (PMID: 34171281) |
| Start Year | 2018 |
| Description | Long term pregnancy outcomes of women with cancer following fertility preservation: A systematic review and meta-analysis |
| Organisation | Epsom and St Helier University Hospitals NHS Trust |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Members of the research team were commented on the protocol, provided feedback and advice during the project, and commented on the final report |
| Collaborator Contribution | Development of the protocol. Performed all trial searches, completed data extraction, analysis and writing the report |
| Impact | 1 protocol (CRD42021269016) and 1 paper (PMID: 36535069) |
| Start Year | 2021 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | Centre Eugène Marquis |
| Country | France |
| Sector | Public |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | Connolly Hospital Blanchardstown |
| Country | Ireland |
| Sector | Hospitals |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | Curie Institute Paris (Institut Curie) |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | Erasmus MC |
| Country | Netherlands |
| Sector | Hospitals |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | Gustave-Roussy Institute |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | Hospitals Essen-Mitte |
| Country | Germany |
| Sector | Hospitals |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | Karolinska Institute |
| Country | Sweden |
| Sector | Academic/University |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | Leiden University |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | Lille University Hospital |
| Country | France |
| Sector | Hospitals |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | NRG Oncology |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | National Institute for Health Research |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | Netherlands Cancer Institute (NKI) |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | North Carolina Institute of Medicine |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | Queensland Government |
| Department | Princess Alexandra Hospital (Australia) |
| Country | Australia |
| Sector | Hospitals |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | St Luke's Hospital, Dublin |
| Country | Ireland |
| Sector | Hospitals |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | Sun Yat-Sen University |
| Country | China |
| Sector | Academic/University |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | University of Hong Kong |
| Country | Hong Kong |
| Sector | Academic/University |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | University of Leipzig |
| Country | Germany |
| Sector | Academic/University |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | University of Michigan |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | University of Padova |
| Country | Italy |
| Sector | Academic/University |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | University of Paris-Saclay |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | University of Queensland |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | University of Sydney |
| Department | NHMRC Clinical Trials Centre |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | MANATEC-02. Individual Participant Data Network Meta-Analysis of Neoadjuvant Chemotherapy or Chemoradiotherapy in Esophageal or Gastroesophageal Junction Carcinoma |
| Organisation | University of Texas |
| Department | M. D. Anderson Cancer Center |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Conception and design, manuscript writing and final approval of manuscript |
| Collaborator Contribution | Conception and design, administrative support, provision of study materials or patients, collection and assembly of data, data analysis and interpretation, manuscript writing and final approval of manuscript |
| Impact | Protocol https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=107158 Publication DOI:10.1200/JCO.22.02279 |
| Start Year | 2018 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Acibadem University |
| Country | Turkey |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Aix-Marseille University |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Alexander Fleming Institute |
| Country | Argentina |
| Sector | Charity/Non Profit |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | American University of Beirut Medical Center |
| Country | Lebanon |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Ankara University |
| Country | Turkey |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Belfast City Hospital |
| Country | United Kingdom |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Brussels Saint-Luc University Hospital (UCL) |
| Country | Belgium |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Carolina Urologic Research Center |
| Country | United States |
| Sector | Public |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Cleveland Clinic |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Copenhagen University Hospital |
| Country | Denmark |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Cornell University |
| Department | Weill Cornell Medicine |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Dana-Farber Cancer Institute |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Duke University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Essen University Hospital |
| Country | Germany |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Fudan University |
| Country | China |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Fundación Marques de Valdecilla |
| Country | Spain |
| Sector | Charity/Non Profit |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Ghent University Hospital |
| Country | Belgium |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Grochowski Hospital |
| Country | Poland |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Gustave-Roussy Institute |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Guy's and St Thomas' NHS Foundation Trust |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Hong Kong Sanatorium and Hospital |
| Country | Hong Kong |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Hospital 12 de Octubre |
| Country | Spain |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Icahn School of Medicine at Mount Sinai |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Innlandet Hospital Trust |
| Country | Norway |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Instituto de Investigación Biomédica de Málaga |
| Country | Spain |
| Sector | Public |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Kindai University Hospital |
| Country | Japan |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | King Saud University |
| Country | Saudi Arabia |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Massachusetts General Hospital |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Massachusetts General Hospital |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Medical University of Vienna |
| Country | Austria |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Memorial Sloan Kettering Cancer Center |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Mohamed V University |
| Country | Morocco |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Monash University |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Mount Vernon Hospital |
| Country | United Kingdom |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | National Cancer Centre Singapore |
| Country | Singapore |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Northwestern University |
| Department | Feinberg School of Medicine |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Oregon Health and Science University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Paoli-Calmettes Institute |
| Country | France |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Peter MacCallum Cancer Centre |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Prostate Cancer Foundation |
| Country | Global |
| Sector | Charity/Non Profit |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Radboud University Nijmegen |
| Country | Netherlands |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Royal Marsden Hospital |
| Country | United Kingdom |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Salford Royal Hospital |
| Department | Christie at Salford Royal Hospital |
| Country | United Kingdom |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | San Raffaele Hospital |
| Country | Italy |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Santa Chiara Hospital |
| Country | Italy |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Sheffield Teaching Hospitals NHS Foundation Trust |
| Country | United Kingdom |
| Sector | Public |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Skåne University Hospital |
| Country | Sweden |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Stanford University |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Tampere University Hospital |
| Country | Finland |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Tata Memorial Hospital |
| Country | India |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Tel Aviv University |
| Country | Israel |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | The Methodist Hospital, Houston |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | The Hospital Israelita Albert Einstein |
| Country | Spain |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Toho University Medical Center Sakura Hospital |
| Country | Japan |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Tulane Medical Center |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University Hospital La Princesa |
| Country | Spain |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University Hospital Schleswig-Holstein |
| Country | Germany |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University Hospitals Seidman Cancer Center |
| Country | United States |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University Medical Center Hamburg-Eppendorf |
| Country | Germany |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Adelaide |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Bern |
| Country | Switzerland |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Bologna |
| Country | Italy |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of British Columbia |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of British Columbia |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of California, Davis |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of California, San Francisco |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Franche-Comté |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Glasgow |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Lugano |
| Country | Switzerland |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Manchester |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Melbourne |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Miami |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Milan |
| Country | Italy |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Minnesota |
| Department | Minnesota NMR Center |
| Country | United States |
| Sector | Charity/Non Profit |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Minnesota |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Montreal |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Paris-Saclay |
| Country | France |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Pennsylvania |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Port Harcourt Teaching Hospital |
| Country | Nigeria |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of South Florida |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Sydney |
| Country | Australia |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Texas |
| Department | M. D. Anderson Cancer Center |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Toronto |
| Country | Canada |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Washington |
| Country | United States |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | University of Zurich |
| Country | Switzerland |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Vall d'Hebron Institute of Oncology |
| Country | Spain |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Walsall College |
| Country | United Kingdom |
| Sector | Academic/University |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Management of patients with advanced prostate cancer-metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022 |
| Organisation | Yokohama City University Medical Centre |
| Country | Japan |
| Sector | Hospitals |
| PI Contribution | Writing, reviewing and editing the manuscript |
| Collaborator Contribution | Conceptualization, Methodology, Data Curation, Writing - Original Draft, Writing - Review & Editing, Supervision, Project administration |
| Impact | https://doi.org/10.1016/j.ejca.2023.02.018 |
| Start Year | 2022 |
| Description | Multivariate Meta-analysis Using IPD (Chapter 13). In: Individual participant data meta-analysis: A handbook for healthcare research |
| Organisation | AstraZeneca |
| Country | United Kingdom |
| Sector | Private |
| PI Contribution | Co-authored the chapter |
| Collaborator Contribution | Co-authored the chapter. One partner led writing the chapter and was co-editor of book |
| Impact | 1 book chapter (Chapter 13) |
| Start Year | 2015 |
| Description | Multivariate Meta-analysis Using IPD (Chapter 13). In: Individual participant data meta-analysis: A handbook for healthcare research |
| Organisation | Keele University |